Keros Therapeutics (KROS) Prepaid Assets (2019 - 2025)
Keros Therapeutics (KROS) posted Prepaid Assets of $2.4 million for Q4 2025, down 89.27% on a QoQ basis from $22.3 million in Q3 2025, and down 90.86% year-over-year from $26.2 million in Q4 2024.
Keros Therapeutics (KROS) Prepaid Assets (2019 - 2025) Analysis & Trends
Keros Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $2.4 million for Q4 2025.
- Quarterly Prepaid Assets fell 90.86% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (down 90.86% YoY) and the FY2025 annual result came in at $2.4 million, down 90.86% from the prior year.
- Prepaid Assets was $2.4 million for Q4 2025 at Keros Therapeutics, down from $22.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $26.8 million in Q2 2024 and bottomed at $210000.0 in Q4 2021.
- A 5-year average of $10.8 million and a median of $5.7 million in 2021 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets jumped 7040.16% — and 2025, when it plunged 90.86%.
- Keros Therapeutics' Prepaid Assets stood at $210000.0 in 2021, then jumped by 3099.52% to $6.7 million in 2022, then slumped by 85.1% to $1.0 million in 2023, then jumped by 2519.38% to $26.2 million in 2024, then plunged by 90.86% to $2.4 million in 2025.
- Business Quant data shows KROS's Prepaid Assets at $2.4 million in Q4 2025, $22.3 million in Q3 2025, and $26.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Keros Therapeutics | 377.42 Mn | 90.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 22.34 Mn |
| Jun 30, 2025 | 26.78 Mn |
| Mar 31, 2025 | 21.68 Mn |
| Dec 31, 2024 | 26.22 Mn |
| Sep 30, 2024 | 20.97 Mn |
| Jun 30, 2024 | 26.85 Mn |
| Mar 31, 2024 | 20.46 Mn |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 16.54 Mn |
| Jun 30, 2023 | 376,000.00 |
| Mar 31, 2023 | 10.79 Mn |
| Dec 31, 2022 | 6.72 Mn |
| Sep 30, 2022 | 745,000.00 |
| Jun 30, 2022 | 466,000.00 |
| Mar 31, 2022 | 2.63 Mn |
| Dec 31, 2021 | 210,000.00 |
| Sep 30, 2021 | 4.73 Mn |
| Jun 30, 2021 | 4.20 Mn |
| Mar 31, 2021 | 265,000.00 |